SCHEMBL2828800

SCHEMBL2828800

O=C(COc1ccc(OC(F)(F)F)cc1)N1CCC(N2CCCC2)CC1

nearest known ligand 0.67

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ACHE P22303 8/20 0.67
CYP2D6 P10635 1/20 0.58
CYP2C19 P33261 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
HRH3 Q9Y5N1 2/20 0.58
KDM4E B2RXH2 2/20 0.55
ALDH1A1 P00352 1/20 0.51
TP53 P04637 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
MCHR1 Q99705 2/20 0.51
POLB P06746 1/20 0.50
MCHR2 Q969V1 1/20 0.50
MAPT P10636 1/20 0.50
HPGD P15428 1/20 0.50
RAB9A P51151 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4375397 0.90 KDM4E (0.68) ACHEHRH3KDM4EALDH1A1SMN1; SMN2
SCHEMBL4375413 0.89 KDM4E (0.67) ACHECYP2D6CYP2C19NPSR1HRH3
SCHEMBL2836569 0.86 ACHE (0.72) ACHECYP2D6CYP2C19NPSR1KDM4E
SCHEMBL2836399 0.85 HRH3 (0.58) ACHEHRH3KDM4EALDH1A1SMN1; SMN2
SCHEMBL3774733 0.84 KDM4E (0.57) ACHEHRH3KDM4EALDH1A1SMN1; SMN2
SCHEMBL2829771 0.84 ACHE (0.73) ACHECYP2D6CYP2C19NPSR1KDM4E
SCHEMBL2829286 0.81 ACHE (0.69) ACHECYP2D6CYP2C19NPSR1KDM4E
SCHEMBL182672 0.81 ACHE (0.68) ACHECYP2D6CYP2C19NPSR1KDM4E
SCHEMBL656497 0.78 TPSAB1 (0.70) HRH3ALDH1A1POLBMAPTHPGD
SCHEMBL15134818 0.78 HRH3 (0.71) HRH3ALDH1A1TP53TDP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2243776-A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor High Point Pharmaceuticals, LLC (US) 2010-10-27 EP claimed
EP-2243776-A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor High Point Pharmaceuticals, LLC (US) 2010-10-27 EP disclosed
US-7064135-B2 Substituted piperidines NOVO NORDISK INC. (DK) 2006-06-20 US disclosed